Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents
- 1 June 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (12) , 1351-1356
- https://doi.org/10.1016/0960-894x(96)00224-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Fibrinogen receptor antagonists - a novel class of promising antithromboticsDrugs of the Future, 1994
- Antithrombotic Effects and Bleeding Time Prolongation with Synthetic Platelet GPIIb/llla Inhibitors in Animal Models of Platelet-Mediated ThrombosisThrombosis and Haemostasis, 1994
- The Effects of Two Synthetic Glycoprotein II b/III a Antagonists, Ro 43-8857 and L-700,462, on Platelet Aggregation and Bleeding in Guinea-Pigs and Dogs: Evidence that Ro 43-8857 Is Orally ActiveThrombosis and Haemostasis, 1993
- Aminopeptidase resistant Arg‐Gly‐Asp analogs are stable in plasma and inhibit platelet aggregationInternational Journal of Peptide and Protein Research, 1991
- Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms.Circulation, 1990
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Sequestration of platelets in the pulmonary circulation as a consequence of protamine reversal of the anticoagulant effects of heparinJournal of Vascular Surgery, 1987
- Studies on peptides. CLV. Evaluation of trimethylsilyl bromide as a hard-acid deprotecting reagent in peptide synthesis.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Platelet aggregation by fibrinogen polymers crosslinked across the E domainBlood, 1986
- Platelets and extracorporeal circulationBiomaterials, 1982